Logo image of EHC

ENCOMPASS HEALTH CORP (EHC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EHC - US29261A1007 - Common Stock

107.185 USD
-0.86 (-0.79%)
Last: 12/10/2025, 10:17:46 AM
Fundamental Rating

6

Overall EHC gets a fundamental rating of 6 out of 10. We evaluated EHC against 100 industry peers in the Health Care Providers & Services industry. EHC has an excellent profitability rating, but there are some minor concerns on its financial health. EHC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year EHC was profitable.
EHC had a positive operating cash flow in the past year.
EHC had positive earnings in each of the past 5 years.
Each year in the past 5 years EHC had a positive operating cash flow.
EHC Yearly Net Income VS EBIT VS OCF VS FCFEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

EHC has a Return On Assets of 7.85%. This is amongst the best in the industry. EHC outperforms 91.00% of its industry peers.
EHC's Return On Equity of 22.71% is amongst the best of the industry. EHC outperforms 89.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.98%, EHC belongs to the top of the industry, outperforming 89.00% of the companies in the same industry.
EHC had an Average Return On Invested Capital over the past 3 years of 10.83%. This is in line with the industry average of 9.44%.
The 3 year average ROIC (10.83%) for EHC is below the current ROIC(12.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.85%
ROE 22.71%
ROIC 12.98%
ROA(3y)5.82%
ROA(5y)5.56%
ROE(3y)21.24%
ROE(5y)20.61%
ROIC(3y)10.83%
ROIC(5y)9.67%
EHC Yearly ROA, ROE, ROICEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 9.30%, EHC belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
EHC's Profit Margin has improved in the last couple of years.
The Operating Margin of EHC (17.29%) is better than 94.00% of its industry peers.
EHC's Operating Margin has been stable in the last couple of years.
EHC has a Gross Margin of 95.65%. This is amongst the best in the industry. EHC outperforms 99.00% of its industry peers.
EHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.29%
PM (TTM) 9.3%
GM 95.65%
OM growth 3Y-0.68%
OM growth 5Y1.36%
PM growth 3Y-6.23%
PM growth 5Y1.66%
GM growth 3Y0.05%
GM growth 5Y-0.17%
EHC Yearly Profit, Operating, Gross MarginsEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EHC is creating some value.
Compared to 1 year ago, EHC has more shares outstanding
Compared to 5 years ago, EHC has more shares outstanding
The debt/assets ratio for EHC has been reduced compared to a year ago.
EHC Yearly Shares OutstandingEHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EHC Yearly Total Debt VS Total AssetsEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.03 indicates that EHC is not in any danger for bankruptcy at the moment.
The Altman-Z score of EHC (3.03) is better than 62.00% of its industry peers.
The Debt to FCF ratio of EHC is 6.04, which is on the high side as it means it would take EHC, 6.04 years of fcf income to pay off all of its debts.
EHC has a better Debt to FCF ratio (6.04) than 61.00% of its industry peers.
EHC has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.01, EHC is not doing good in the industry: 61.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 6.04
Altman-Z 3.03
ROIC/WACC1.52
WACC8.57%
EHC Yearly LT Debt VS Equity VS FCFEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.14 indicates that EHC should not have too much problems paying its short term obligations.
The Current ratio of EHC (1.14) is worse than 61.00% of its industry peers.
A Quick Ratio of 1.14 indicates that EHC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.14, EHC is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
EHC Yearly Current Assets VS Current LiabilitesEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.80% over the past year.
EHC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.58% yearly.
The Revenue has grown by 11.13% in the past year. This is quite good.
EHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.13% yearly.
EPS 1Y (TTM)22.8%
EPS 3Y1.63%
EPS 5Y2.58%
EPS Q2Q%19.42%
Revenue 1Y (TTM)11.13%
Revenue growth 3Y10.2%
Revenue growth 5Y3.13%
Sales Q2Q%9.36%

3.2 Future

Based on estimates for the next years, EHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.24% on average per year.
Based on estimates for the next years, EHC will show a quite strong growth in Revenue. The Revenue will grow by 8.33% on average per year.
EPS Next Y20.82%
EPS Next 2Y15.1%
EPS Next 3Y12.88%
EPS Next 5Y12.24%
Revenue Next Year10.92%
Revenue Next 2Y9.84%
Revenue Next 3Y9.27%
Revenue Next 5Y8.33%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EHC Yearly Revenue VS EstimatesEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
EHC Yearly EPS VS EstimatesEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.73, which indicates a rather expensive current valuation of EHC.
EHC's Price/Earnings ratio is a bit cheaper when compared to the industry. EHC is cheaper than 70.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.29, EHC is valued a bit cheaper.
A Price/Forward Earnings ratio of 18.26 indicates a rather expensive valuation of EHC.
Based on the Price/Forward Earnings ratio, EHC is valued a bit cheaper than the industry average as 62.00% of the companies are valued more expensively.
EHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.73
Fwd PE 18.26
EHC Price Earnings VS Forward Price EarningsEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

73.00% of the companies in the same industry are more expensive than EHC, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as EHC.
Industry RankSector Rank
P/FCF 26.79
EV/EBITDA 9.98
EHC Per share dataEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EHC has an outstanding profitability rating, which may justify a higher PE ratio.
EHC's earnings are expected to grow with 12.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)8.03
EPS Next 2Y15.1%
EPS Next 3Y12.88%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.67%, EHC is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.55, EHC pays a better dividend. On top of this EHC pays more dividend than 83.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, EHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.67%

5.2 History

The dividend of EHC decreases each year by -10.71%.
EHC has been paying a dividend for at least 10 years, so it has a reliable track record.
EHC has decreased its dividend recently.
Dividend Growth(5Y)-10.71%
Div Incr Years1
Div Non Decr Years1
EHC Yearly Dividends per shareEHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

EHC pays out 12.82% of its income as dividend. This is a sustainable payout ratio.
DP12.82%
EPS Next 2Y15.1%
EPS Next 3Y12.88%
EHC Yearly Income VS Free CF VS DividendEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EHC Dividend Payout.EHC Dividend Payout, showing the Payout Ratio.EHC Dividend Payout.PayoutRetained Earnings

ENCOMPASS HEALTH CORP

NYSE:EHC (12/10/2025, 10:17:46 AM)

107.185

-0.86 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners97.58%
Inst Owner Change1.4%
Ins Owners1.23%
Ins Owner Change-0.01%
Market Cap10.78B
Revenue(TTM)5.80B
Net Income(TTM)539.10M
Analysts87.06
Price Target143.14 (33.54%)
Short Float %2.67%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield 0.67%
Yearly Dividend0.62
Dividend Growth(5Y)-10.71%
DP12.82%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-02 2026-01-02 (0.19)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.29%
Min EPS beat(2)1.94%
Max EPS beat(2)14.64%
EPS beat(4)4
Avg EPS beat(4)10.91%
Min EPS beat(4)1.94%
Max EPS beat(4)14.64%
EPS beat(8)8
Avg EPS beat(8)11.75%
EPS beat(12)12
Avg EPS beat(12)13.3%
EPS beat(16)14
Avg EPS beat(16)9.44%
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.16%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.16%
Revenue beat(8)5
Avg Revenue beat(8)0.39%
Revenue beat(12)9
Avg Revenue beat(12)0.44%
Revenue beat(16)10
Avg Revenue beat(16)-3.55%
PT rev (1m)0.9%
PT rev (3m)3.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.2%
EPS NY rev (1m)0.05%
EPS NY rev (3m)1.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 20.73
Fwd PE 18.26
P/S 1.86
P/FCF 26.79
P/OCF 9.73
P/B 4.54
P/tB 13.85
EV/EBITDA 9.98
EPS(TTM)5.17
EY4.82%
EPS(NY)5.87
Fwd EY5.48%
FCF(TTM)4
FCFY3.73%
OCF(TTM)11.02
OCFY10.28%
SpS57.6
BVpS23.59
TBVpS7.74
PEG (NY)1
PEG (5Y)8.03
Graham Number52.39
Profitability
Industry RankSector Rank
ROA 7.85%
ROE 22.71%
ROCE 16.42%
ROIC 12.98%
ROICexc 13.16%
ROICexgc 17.91%
OM 17.29%
PM (TTM) 9.3%
GM 95.65%
FCFM 6.95%
ROA(3y)5.82%
ROA(5y)5.56%
ROE(3y)21.24%
ROE(5y)20.61%
ROIC(3y)10.83%
ROIC(5y)9.67%
ROICexc(3y)10.95%
ROICexc(5y)9.82%
ROICexgc(3y)15.47%
ROICexgc(5y)15.57%
ROCE(3y)13.69%
ROCE(5y)12.22%
ROICexgc growth 3Y1.55%
ROICexgc growth 5Y-5.09%
ROICexc growth 3Y12.32%
ROICexc growth 5Y3.22%
OM growth 3Y-0.68%
OM growth 5Y1.36%
PM growth 3Y-6.23%
PM growth 5Y1.66%
GM growth 3Y0.05%
GM growth 5Y-0.17%
F-Score9
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 6.04
Debt/EBITDA 1.81
Cap/Depr 220.91%
Cap/Sales 12.18%
Interest Coverage 250
Cash Conversion 83.87%
Profit Quality 74.68%
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 3.03
F-Score9
WACC8.57%
ROIC/WACC1.52
Cap/Depr(3y)222.37%
Cap/Depr(5y)209.98%
Cap/Sales(3y)12.51%
Cap/Sales(5y)12.54%
Profit Quality(3y)67.08%
Profit Quality(5y)69.21%
High Growth Momentum
Growth
EPS 1Y (TTM)22.8%
EPS 3Y1.63%
EPS 5Y2.58%
EPS Q2Q%19.42%
EPS Next Y20.82%
EPS Next 2Y15.1%
EPS Next 3Y12.88%
EPS Next 5Y12.24%
Revenue 1Y (TTM)11.13%
Revenue growth 3Y10.2%
Revenue growth 5Y3.13%
Sales Q2Q%9.36%
Revenue Next Year10.92%
Revenue Next 2Y9.84%
Revenue Next 3Y9.27%
Revenue Next 5Y8.33%
EBIT growth 1Y21.88%
EBIT growth 3Y9.45%
EBIT growth 5Y4.54%
EBIT Next Year52.35%
EBIT Next 3Y21.51%
EBIT Next 5YN/A
FCF growth 1Y54.97%
FCF growth 3Y29.84%
FCF growth 5Y9.28%
OCF growth 1Y34.84%
OCF growth 3Y11.89%
OCF growth 5Y9.56%

ENCOMPASS HEALTH CORP / EHC FAQ

What is the fundamental rating for EHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to EHC.


Can you provide the valuation status for ENCOMPASS HEALTH CORP?

ChartMill assigns a valuation rating of 5 / 10 to ENCOMPASS HEALTH CORP (EHC). This can be considered as Fairly Valued.


Can you provide the profitability details for ENCOMPASS HEALTH CORP?

ENCOMPASS HEALTH CORP (EHC) has a profitability rating of 9 / 10.


What is the earnings growth outlook for ENCOMPASS HEALTH CORP?

The Earnings per Share (EPS) of ENCOMPASS HEALTH CORP (EHC) is expected to grow by 20.82% in the next year.


How sustainable is the dividend of ENCOMPASS HEALTH CORP (EHC) stock?

The dividend rating of ENCOMPASS HEALTH CORP (EHC) is 4 / 10 and the dividend payout ratio is 12.82%.